EB148

Programme of Work

No1 - 19 January 2021 No2 - 20 January 2021 No3 - 21 January 2021 No4 - 22 January 2021 No5 - 23 January 2021 No6 - 25 January 2021 No7 - 26 January 2021

Main documents

Information documents

Main documents

EB148/1 Rev.1
Agenda

EB148/1(annotated)
Provisional agenda (annotated)

EB148/2
Opening of the session and adoption of the agenda
Special procedures

EB148/3
Report by the Director-General

EB148/4
Report of the regional committees to the Executive Board

EB148/5
Report of the Programme, Budget and Administration Committee of the Executive Board

EB148/6
Global action on patient safety

EB148/6 Add.1
Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Executive Board

EB148/7
Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases

EB148/7 Add.1
Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases
Mid-point evaluation of the implementation of the WHO global action plan for the prevention and control of noncommunicable diseases 2013–2020
Executive summary

EB148/7 Add.2
Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases
Final evaluation of the global coordination mechanism on the prevention and control of noncommunicable diseases
Executive summary

EB148/7 Add.3
Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Executive Board

EB148/8
Oral health
Achieving better oral health as part of the universal health coverage and noncommunicable disease agendas towards 2030

EB148/9
Expanding access to effective treatments for cancer and rare and orphan diseases, including medicines, vaccines, medical devices, diagnostics, assistive products, cell- and gene-based therapies and other health technologies; and improving the transparency of markets for medicines, vaccines, and other health products

EB148/10
Global strategy and plan of action on public health, innovation and intellectual property

EB148/11
Antimicrobial resistance

EB148/12
Substandard and falsified medical products

EB148/13
Standardization of medical devices nomenclature

EB148/14
Immunization Agenda 2030

EB148/15
Integrated people-centred eye care, including preventable vision impairment and blindness

EB148/16
COVID-19 response

EB148/17
Public health emergencies: preparedness and response
WHO’s work in health emergencies

EB148/18
WHO’s work in health emergencies
Strengthening WHO’s global emergency preparedness and response

EB148/19
Strengthening preparedness for health emergencies: implementation of the International Health Regulations (2005)
Interim progress report of the Review Committee on the Functioning of the International Health Regulations (2005) during the COVID-19 Response

EB148/20
Mental health preparedness and response for the COVID-19 pandemic

EB148/21
The public health implications of implementation of the Nagoya Protocol

EB148/22
Poliomyelitis
Poliomyelitis eradication

EB148/23
Poliomyelitis
Polio transition planning and polio post-certification

EB148/24
Social determinants of health

EB148/25
Proposed programme budget 2022–2023
Building forward better

EB148/25 Add.1
Progress towards achieving the United Nations System-wide Action Plan on Gender Equality and the Empowerment of Women

EB148/26
Sustainable financing

EB148/26 Add.1 Rev.1
Sustainable financing
DRAFT DECISION

EB148/26 Add.2
Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Executive Board

EB148/27
Update on the financing and implementation of the Programme budget 2020–2021

EB148/28
Scale of assessments 2022–2023

EB148/29
Status of collection of assessed contributions, including Member States in arrears in the payment of their contributions to an extent that would justify invoking Article 7 of the Constitution

EB148/30
Update on Information management and technology

EB148/31
Update on the Infrastructure Fund
Geneva buildings renovation strategy

EB148/32
WHO transformation
Transforming for enhanced country impact

EB148/33
WHO reform
Governance

EB148/33 Add.1
Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Executive Board

EB148/34
WHO reform
World health days

EB148/35
WHO reform
Involvement of non-State actors in WHO’s governing bodies

EB148/36
Global strategies and plans of action that are scheduled to expire within one year
WHO global disability action plan 2014–2021: better health for all people with disability

EB148/37
The global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections, for the period 2016–2021

EB148/38
Process for the election of the Director-General of the World Health Organization

EB148/38 Add.1
Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Executive Board

EB148/39
Engagement with non-State actors
Report on the implementation of the Framework of Engagement with Non-State Actors

EB148/40
Engagement with non-State actors
Non-State actors in official relations with WHO

EB148/40 Add.1
Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Executive Board

EB148/41
Provisional agenda of the Seventy-fourth World Health Assembly

EB148/42
Date and place of the 149th session of the Executive Board

EB148/43
Foundation committees and selection panels

EB148/44
Human resources update

EB148/45
Amendments to the Staff Regulations and Staff Rules

EB148/45 Add.1
Financial and administrative implications for the Secretariat of resolutions proposed for adoption by the Executive Board

EB148/46
Note: Document EB148/46 will not be issued; instead, the Secretariat will provide a verbal update.

EB148/47
Report on meetings of expert committees and study groups

EB148/47 Add.1
Report on meetings of expert committees and study groups
Expert advisory panels and committees and their membership

Information documents

EB148/INF./1
Statement by the representative of the WHO staff associations

EB148/INF./2
Report of the Ombudsman

EB148/INF./3
Report of the Ombudsman
Ombudsman’s recommendations: progress on implementation

EB148/INF./4
Second report on progress by the Independent Panel for Pandemic Preparedness and Response

EB148/INF./5
Decision-making and procedural issues on the virtual system
A practical guide

Diverse documents

EB148/DIV./1 Rev.1
Liste des membres et autres participants
List of members and other participants
MEMBRES, SUPPLEANTS ET CONSEILLERS
MEMBERS, ALTERNATES AND ADVISERS

EB148/DIV./2
Preliminary daily timetable

EB148/DIV./3
List of decisions and resolutions

EB148/DIV./4
List of documents

Resolutions

EB148/2021/REC/1
Resolutions, decisions and annexes

Decisions

EB148/2021/REC/1
Resolutions, decisions and annexes

Conf. Paper

Statements by non-State actors in official relations at WHO governing bodies meetings Regional committees 2020: summary reports Pre-session documentation planning profile Template for the explanatory memorandum for the inclusion of items on the provisional agenda of the Health Assembly Report of the International Civil Service Commission for the year 2020 (document A/75/60) Presentation to EB148 on ACT Accelerator & COVAX Presentation to EB148: COVID-19 situation and strategic response Presentation to EB: Strengthening WHO’s Global Emergency Preparedness and Response

The recordings of the EB145 live webcast will be available on this link for three months after closure of the session.

The interpretation of proceedings serves to facilitate communication and does not constitute an authentic or verbatim record of the proceedings. Only the original speech is authentic.

Registered
meeting attendee?

Download the meeting App: Apple Android Web